One forward, three back: Court Order Undermines Effectiveness of Zantac MDL

Nov 15, 2022

Posted by : ZeroRisk Cases Marketing

By Christina Grube (MASS TORT NEWS) U.S. District Judge Robin Rosenburg’s recent order reducing the number of cancers accepted under the Zantac MDL 2924 may serve to undermine the purpose and effectiveness of the MDL itself. In January, Judge Rosenburg reduced the number of cancers from 10 to 5, removing certain cancers (breast, prostate, colorectal, […]

The post One forward, three back: Court Order Undermines Effectiveness of Zantac MDL appeared first on Mass Tort News.

Be Sociable, Share!

Nov 15, 2022

Posted by : ZeroRisk Cases Marketing

Recent Posts

Categories

Archives